Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia

Clinical and Experimental Rheumatology

Volumn 28, Issue 1 SUPPL. 57, 2010, Pages

  Quartuccio, Luca ^a   Petrarca, Antonio ^b   Mansutti, Elisa ^a   Pieroni, Stefano ^c   Calcabrini, Lucia ^c   Avellini, C ^d   Zignego, Anna Linda ^b   De Vita, Salvatore ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Ospedale di Macerata   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

Intestinal vasculitis; Mixed cryoglobulinemia; Rituximab

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; RITUXIMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; COLIC; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; CYTOMEGALOVIRUS COLITIS; DEATH; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; ENDOSCOPY; ENTEROPATHY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HEMATOCHEZIA; HEPATORENAL SYNDROME; HUMAN; HYPOVOLEMIC SHOCK; INFLAMMATION; INTESTINAL VASCULITIS; INTESTINE BIOPSY; MAINTENANCE THERAPY; MALE; OCCULT BLOOD TEST; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PURPURA; SKIN ULCER; VASCULITIS; VOMITING; ABDOMINAL DISEASE; ABDOMINAL VASCULITIS; DIGESTIVE TRACT ENDOSCOPY; DISEASE SEVERITY; HISTOPATHOLOGY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; BIOPSY; CASE REPORT; GASTROINTESTINAL TRACT; HOSPITALIZATION; PATHOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOPSY; CRYOGLOBULINEMIA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULITIS;

EID: 77954577305     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BAXTER R, NINO-MURICIA M, BLOOM RJ, KOSEK J: Gastrointestinal manifestations of essential mixed cryoglobulinemia. Gastrointest Radiol 1988; 13: 160-2.
2. CACOUB P, LUNEL-FABIANI F, DU LT: Systemic vasculitis in patients with hepatitis C virus infection. J Rheumatol 2001 ; 28: 108-18.
3. FERRI C, SEBASTIANI M, GIUGGIOLI D et al.: Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-74.
4. RAMOS-CASALS M, ROBLES A, BRITO-ZERÓN P et al.: Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006; 36: 189-96.
5. DELLA ROSSA A, MARCHI F, CATARSI E, TAVONI A, BOMBARDIERI S: Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S105-8.
6. JONES MP, PANDAK WM, MOXLEY GF: Chronic diarrhea in essential mixed cryoglobulinemia: a manifestation of visceral vasculitis? Am J Gastroenterol 1991; 86: 522-4.
7. ZAJA F, DE VITA S, MAZZARO C et al.: Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-34.
8. SANSONNO D, DE RE V, LAULETTA G, TUCCI FA, BOIOCCHI M, DAMMACCO F: Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 2003; 101: 3818-26.
9. ROCCATELLO D, BALDOVINO S, ROSSI D et al.: Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 2004; 19: 3054-61.
10. QUARTUCCIO L, SOARDO G, ROMANO G et al.: Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) 2006; 45: 842-6.
11. ROCCATELLO D, BALDOVINO S, ALPA M et al.: Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S67-71.
12. LAMPRECHT P, LERIN-LOZANO C, MERZ H et al.: Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2003; 62: 1230-3.
13. KOUKOULAKI M, ABEYGUNASEKARA SC, SMITH KG, JAYNE DR: Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Nephrol Dial Transplant 2005; 20: 213-6.
14. VISENTINI M, GRANATA M, VENEZIANO ML et al.: Efficacy of low-dose rituximab for mixed cryoglobulinemia. Clin Immunol 2007; 125: 30-3.
15. GONZALEZ-GAY MA, VAZQUEZ-RODRIGUEZ TR, MIRANDA-FILLOY JA, PAZOS-FERRO A, GARCIA-RODEJA E: Localized vasculitis of the gastrointestinal tract: a case report and literature review. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S101-4.
16. DE VITA S, QUARTUCCIO L, GREMESE E, FERRACCIOLI GF: Gastrointestinal involvement insystemic vasculitis. In: ASHERSON R, RODES J, RAMOS-CASALS M (Eds.) Digestive involvement in systemic autoimmune diseases. Handbook of systemic autoimmune diseases series. Elsevier Science & Technology Books 2008: 83.
17. CACOUB P, LUNEL-FABIANI F, DU LT: Systemic vasculitis in patients with hepatitis C virus infection. J Rheumatol 2001; 28: 108-18.
18. COSTEDOAT-CHALUMEAU N, CACOUB P, MAISONOBE T et al.: Renal microaneurysms in three cases of hepatitis C virus-related vasculitis. Rheumatology 2002; 41: 708-10.
19. FERRI C, MASCIA MT: Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18: 54-63.
20. GOREVIC PD, KASSAB HJ, LEVO Y et al.: Mixed crioglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287-308.
21. SAMARKOS M, VAIOPOULOS G, ANDR-EOPOULOS A et al.: Association of protein-losing enteropathy and cryoglobulinemia. Scand J Gastroenterol 2003; 38: 334-6.
22. POMPILI M, PIZZOLANTE F, LAROCCA LM et al.: Ischaemic jejunal vasculitis during treatment with pegylated interferonalpha 2b and ribavirin for hepatitis C virus related cirrhosis. Dig Liver Dis 2005; 38: 352-4.